Regardless of her characteristics, ORIAHNN controlled her heavy bleeding

Proportion of women who met the primary endpoint in ELARIS UF-1 and UF-23-5,7,11

Subgroup analyses of the primary endpoint were explored to assess potential differences in treatment effect across subgroup levels and were not controlled for multiplicity.8

Graph depicting how Oriahnn controlled heavy menstrual bleeding regardless of characteristics Graph depicting how Oriahnn controlled heavy menstrual bleeding regardless of characteristics Graph depicting how Oriahnn controlled heavy menstrual bleeding regardless of characteristics

Baseline patient characteristics

Overall pooled results for primary endpoint in ELARIS UF-1 and UF-2 (n=395)

Subgroup analyses of primary endpoint at Final Month‡ showed consistent results regardless of BMI, race, age, and ethnicity.2